Tas, U. Et Al. 2025. Serum Neuropeptide FFR2 is increased in pregnant women with pre-eclampsia and associated with pregnancy outcomes. Pakistan Journal of Medical Sciences , vol.41, no.2 , 378-383.

Tas, U., Tas, S., KÜME, T., & Yilmaz, O., (2025). Serum Neuropeptide FFR2 is increased in pregnant women with pre-eclampsia and associated with pregnancy outcomes. Pakistan Journal of Medical Sciences , vol.41, no.2, 378-383.

Tas, Ummu Et Al. "Serum Neuropeptide FFR2 is increased in pregnant women with pre-eclampsia and associated with pregnancy outcomes," Pakistan Journal of Medical Sciences , vol.41, no.2, 378-383, 2025

Tas, Ummu Et Al. "Serum Neuropeptide FFR2 is increased in pregnant women with pre-eclampsia and associated with pregnancy outcomes." Pakistan Journal of Medical Sciences , vol.41, no.2, pp.378-383, 2025

Tas, U. Et Al. (2025) . "Serum Neuropeptide FFR2 is increased in pregnant women with pre-eclampsia and associated with pregnancy outcomes." Pakistan Journal of Medical Sciences , vol.41, no.2, pp.378-383.

@article{article, author={Ummu Tas Et Al. }, title={Serum Neuropeptide FFR2 is increased in pregnant women with pre-eclampsia and associated with pregnancy outcomes}, journal={Pakistan Journal of Medical Sciences}, year=2025, pages={378-383} }